In order to investigate the hypothesis that the combination of clarithromycin with other antibacterial agents offers a successful treatment in the eradication of Pseudomonas aeruginosa biofilm, we first determined the activity of eight antimicrobial agents against planktonic cultures of P. aeruginosa isolates by the microdilution technique. Second, we determined the in vitro effects of these antimicrobial agents individually and in combination against planktonic cultures and pre-formed biofilms of P. aeruginosa PA01. Drug combinations with marked activity were tested on biofilms of clinical isolates. The percentages of planktonic culture survival and biofilm persistence were determined using spectrophotometry and scanning electron microscop...
Introduction: Pseudomonas aeruginosa (P. aeruginosa) is a highly resistant opportunistic pathogen an...
Patients suffering from cystic fibrosis (CF) are commonly affected by chronic Pseudomonas aeruginosa...
Biofilms play a role in the pathogenicity of pneumococcal infections. A pharmacodynamic in vitro mod...
Aim: The combination of different antimicrobial agents and subsequent synergetic effects may be bene...
The aim of the study was to investigate the biofilm-production of 60 Pseudomonas aeruginosa strains ...
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (C...
97 p.The antimicrobial activity of western as well as eastern drugs against infections caused by P. ...
Pseudomonas aeruginosa has gained increasing significance as opportunistic pathogens in hospitalised...
Pseudomonas aeruginosa is a major cause of respiratory biofilm-related infections in patients with c...
Aim: The combination of different antimicrobial agents and subsequent synergetic effects may be ben...
Purpose: Cystic fibrosis patients often develop chronic infections with Pseudomonas aeruginosa (PA)....
A common vector of nosocomial infections is Pseudomonas aeruginosa. This opportunistic pathogen is r...
The prognosis of patients with cystic fibrosis (CF) has improved dramatically over the last three de...
Aim of the study was to determine the effect of antibiotics on the formation process and mature biof...
Objectives\ud \ud To evaluate potential anti-biofilm agents for their ability to enhance the activit...
Introduction: Pseudomonas aeruginosa (P. aeruginosa) is a highly resistant opportunistic pathogen an...
Patients suffering from cystic fibrosis (CF) are commonly affected by chronic Pseudomonas aeruginosa...
Biofilms play a role in the pathogenicity of pneumococcal infections. A pharmacodynamic in vitro mod...
Aim: The combination of different antimicrobial agents and subsequent synergetic effects may be bene...
The aim of the study was to investigate the biofilm-production of 60 Pseudomonas aeruginosa strains ...
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (C...
97 p.The antimicrobial activity of western as well as eastern drugs against infections caused by P. ...
Pseudomonas aeruginosa has gained increasing significance as opportunistic pathogens in hospitalised...
Pseudomonas aeruginosa is a major cause of respiratory biofilm-related infections in patients with c...
Aim: The combination of different antimicrobial agents and subsequent synergetic effects may be ben...
Purpose: Cystic fibrosis patients often develop chronic infections with Pseudomonas aeruginosa (PA)....
A common vector of nosocomial infections is Pseudomonas aeruginosa. This opportunistic pathogen is r...
The prognosis of patients with cystic fibrosis (CF) has improved dramatically over the last three de...
Aim of the study was to determine the effect of antibiotics on the formation process and mature biof...
Objectives\ud \ud To evaluate potential anti-biofilm agents for their ability to enhance the activit...
Introduction: Pseudomonas aeruginosa (P. aeruginosa) is a highly resistant opportunistic pathogen an...
Patients suffering from cystic fibrosis (CF) are commonly affected by chronic Pseudomonas aeruginosa...
Biofilms play a role in the pathogenicity of pneumococcal infections. A pharmacodynamic in vitro mod...